GLENMEDE TRUST CO NA - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 99 filers reported holding FIVE PRIME THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,0000.0%2400.0%0.00%
Q2 2020$1,0000.0%2400.0%0.00%
Q1 2020$1,0000.0%2400.0%0.00%
Q4 2019$1,0002400.0%0.00%
Q3 2019$0
-100.0%
2400.0%0.00%
Q2 2019$1,000
-66.7%
2400.0%0.00%
Q1 2019$3,000
+50.0%
2400.0%0.00%
Q4 2018$2,000
-66.7%
240
-18.6%
0.00%
Q1 2018$6,0000.0%2950.0%0.00%
Q4 2017$6,000
-50.0%
2950.0%0.00%
Q3 2017$12,000
+20.0%
2950.0%0.00%
Q2 2017$10,0000.0%2950.0%0.00%
Q1 2017$10,0002950.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
BVF INC/IL 2,781,346$25,867,0003.38%
GREAT POINT PARTNERS LLC 2,398,409$22,305,0002.82%
Sofinnova Investments, Inc. 315,344$2,933,0000.36%
EcoR1 Capital, LLC 326,775$3,039,0000.30%
Rock Springs Capital Management LP 505,000$4,697,0000.22%
Hilltop Holdings Inc. 36,146$336,0000.08%
OXFORD ASSET MANAGEMENT LLP 285,237$2,653,0000.07%
PLATINUM INVESTMENT MANAGEMENT LTD 191,237$1,779,0000.06%
FOX RUN MANAGEMENT, L.L.C. 12,132$113,0000.06%
Virtus ETF Advisers LLC 31,427$292,0000.05%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders